Cargando…
Review: Miglitol has potential as a therapeutic drug against obesity
The number of obese patients has increased annually worldwide. Therefore, there is a strong need to develop a new effective and safe anti-obesity drug. Miglitol is an alpha-glucosidase inhibitor (αGI) that is commonly used as an anti-diabetic drug, and there is growing evidence that it also has anti...
Autores principales: | Sugimoto, Satoru, Nakajima, Hisakazu, Kosaka, Kitaro, Hosoi, Hajime |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666030/ https://www.ncbi.nlm.nih.gov/pubmed/26628904 http://dx.doi.org/10.1186/s12986-015-0048-8 |
Ejemplares similares
-
Miglitol increases energy expenditure by upregulating uncoupling protein 1 of brown adipose tissue and reduces obesity in dietary-induced obese mice
por: Sugimoto, Satoru, et al.
Publicado: (2014) -
Erythropoietin (EPO) ameliorates obesity and glucose homeostasis by promoting thermogenesis and endocrine function of classical brown adipose tissue (BAT) in diet-induced obese mice
por: Kodo, Kazuki, et al.
Publicado: (2017) -
Association of Type 2 Deiodinase Thr92Ala Polymorphism with Pediatric Obesity in Japanese Children: A Case-Control Study
por: Ota, Takeshi, et al.
Publicado: (2022) -
High-fat diet accelerates extreme obesity with hyperphagia in female heterozygous Mecp2-null mice
por: Fukuhara, Shota, et al.
Publicado: (2019) -
Stability-Indicating RP-HPLC Method for Estimation of Miglitol in Bulk and Tablets
por: Shrivastava, B., et al.
Publicado: (2010)